Item 5. OTHER INFORMATION
2K characters. Original on sec.gov · Markdown
Item 5. OTHER INFORMATION
(c) On September 8, 2023, Daniel Gallagher, our Chief Legal, Compliance, and Corporate Affairs Officer adopted a “Rule 10b5-1 trading arrangement” (as defined in Item 408(a) of Regulation S-K) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act pursuant to which he may sell up to 100,000 shares of our Class A common stock on or prior to December 20, 2024. RSUs convert into Class A common stock on a one-for-one basis upon vesting and settlement.
On September 11, 2023, Vlad Tenev, our Chair, Chief Executive Officer, Co-Founder and President, adopted a “Rule 10b5-1 trading arrangement” (as defined in Item 408(a) of Regulation S-K) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act pursuant to which he may sell up to 4,000,000 shares of our Class A common stock on or prior to November 29, 2024. RSUs convert into Class A common stock on a one-for-one basis upon vesting and settlement.
On September 13, 2023, The Baiju Prafulkumar Bhatt Living Trust dated 11/30/17, for which Baiju Bhatt, our Chief Creative Officer, Co-Founder and a member of our Board of Directors, serves as sole trustee, adopted a “Rule 10b5-1 trading arrangement” (as defined in Item 408(a) of Regulation S-K) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act pursuant to which he may sell up to 5,208,868 shares of our Class A common stock on or prior to December 10, 2024. RSUs convert into Class A common stock on a one-for-one basis upon vesting and settlement.
In addition, certain of our officers may, from time to time, make elections to participate in our ESPP and to have shares withheld to cover withholding taxes or pay the exercise price of options, which may be designed to satisfy the affirmative defense conditions of Rule 10b5-1 under the Exchange Act or may constitute “non-Rule 10b5-1 trading arrangements” (as defined in Item 408(c) of Regulation S-K).
Previous: Item 1A. RISK FACTORS · Next: Item 6. EXHIBIT INDEX